In vitro activity and beta-lactamase stability of LJC 10,627.

The in vitro activity of LJC 10,627, a new carbapenem, was compared with those of imipenem, cefotaxime, ceftazidime, and gentamicin. LJC 10,627 inhibited 90% of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter cloacae, Hafnia...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Neu, H C, Gu, J W, Fang, W, Chin, N X
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191596/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510436/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1418
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!